Enveric Biosciences Executes 1-for-15 Reverse Stock SplitEnveric Biosciences, Inc., a Delaware-based biotechnology company, recently filed a Certificate of Amendment of Amended and Restated Certificate of Incorporation to effect a 1-for-15 reverse st

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Enveric Biosciences’s 8K filing here.

About Enveric Biosciences

Enveric Biosciences, Inc develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.